Singapore Institute of Advanced Medicine to Form Strategic Review Committee; Shares Plunge 27%

MT Newswires2024-12-13

Shares of Singapore Institute of Advanced Medicine were down over 27% in recent trading.

Singapore Institute of Advanced Medicine (SGX:9G2) has decided to form a strategic review committee (SRC) to improve the utilization of its proton beam and photon radiation therapy facilities, a filing with the Singapore Exchange said on Wednesday.

The SRC will also review the company's operations and consider appropriate measures to address its funding requirements.

The company's proton beam therapy treatment business has not contributed significantly to its overall revenue with lower patient inflow, the filing added.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment